erlotinib hydrochloride has been researched along with Diabetes Mellitus, Type 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, L; Liang, G; Luo, W; Qian, Y; Wang, J; Wang, Y; Xu, Z; Yin, H; Zheng, C; Zhuang, F | 1 |
| Grabowski, T; Grześkowiak, E; Karbownik, A; Sobańska, K; Szałek, E; Wolc, A | 1 |
2 other study(ies) available for erlotinib hydrochloride and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Inhibition of EGFR-STAT3 attenuates cardiomyopathy in streptozotocin-induced type 1 diabetes.
Topics: Aminosalicylic Acids; Animals; Benzenesulfonates; Cell Line; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; ErbB Receptors; Erlotinib Hydrochloride; Gene Expression; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Phosphorylation; Rats; STAT3 Transcription Factor | 2019 |
The alteration of pharmacokinetics of erlotinib and OSI420 in type 1 diabetic rabbits.
Topics: Animals; Antineoplastic Agents; Blood Glucose; Deoxycytidine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Erlotinib Hydrochloride; Female; Gemcitabine; Male; Protein Kinase Inhibitors; Rabbits | 2016 |